Research Reports
Next Generation Sequencing Market Research Report by Brandessence Market Research | Global Analysis, Industry Factors, Growth Keys, Features, Demand, Share, Size and By Application, By End-User, Region, and Segment Forecasts, 2021 2027
Market Overview:Next Generation Sequencing Market is valued at USD 8.58 Billion in 2020 and expected to reach USD 29.17 Billion by 2027 with a CAGR of 19.1% over the forecast
Published : 3 years ago, on
Market Overview:
Next Generation Sequencing Market is valued at USD 8.58 Billion in 2020 and expected to reach USD 29.17 Billion by 2027 with a CAGR of 19.1% over the forecast period.
Next Generation Sequencing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing number of cancer patients and growing research and development in this field are the significant factors which are driving the growth of the Global Next Generation Sequencing Market.
Next Generation Sequencing Top Companies:
next generation sequencing market report covers prominent players are Thermo Fisher Scientific, Illumina, PerKinElmer, BGI Group, Agilent Technologies, Bio-Rad Laboratories, Eurofins GATC Biotech GmbH, DNASTAR lnc., Genomatrix GmbH, Oxford Nanopore Technologies, F. Hoffman-La Roche Ltd., QIAGEN and others.
Get Sample Copy of this premium report at: https://brandessenceresearch.com/requestSample/PostId/1600
Scope of Next Generation Sequencing Market Report:
The next generation sequencing (NGS) is any of several high throughput approaches of DNA sequencing using the concept of massively parallel processing. Many NGS platforms differ on the basis of engineering configurations and sequencing chemistry. They share the technical paradigm of massive parallel sequencing via spatially separated, clonally amplified DNA templates or single DNA molecule in a flow cell. NGS is also known capillary sequencing, massive parallel sequencing or massively parallel sequencing. Next generation sequencing technologies are currently used for whole genome sequencing, investigation of genome diversity, epigenetic, metagenomics, identification of non-coding RNSs and protein binding sites and gene expression profiling by RNA sequencing. These are also used in microbiology and virology for detecting various microorganisms and viruses by using metagenomic approaches, investigation microbial communities in the human bodies and environment. And, it is also used for analysis of viral genome variability within the host and detection of low abundance antiviral drug resistance mutations in HIV patients. Some of these sequencing technologies emerged in 1994-1998 and have been commercially available since 2005.
The COVID-19 outbreak has positive impact on next generation sequencing (NGS) market. Various major players and new startups in NGO market have came forward to support the research on testing kits, vaccines and treatment for affected patients as plays an important role in the clinical labs and research to fight against the SARS-CoV-2, which results in the COVID-19. Thus, the COVID-19 has overall shown a positive impact on the growth of NGS market.
News:
Ancestry Launched New Next Generation Sequencing Tool
On August 5th, 2020; Consumer genomic company Ancestry launched a new product – dubbed Ancestry Health powered by NGS. This product will screen users for the genes associated with breast cancer, colon cancer, blood disorders and heart diseases. The service was developed by Quest Diagnostics and price of it is $179. This tool can examine harder-to-sequence variants of the human genome than traditional microarray tech. Now, consumers are spending less on nonessential items – so, the hefty price tags of DTC genetic tests will likely drive consumers further away from these products. This tool could help patients cut back on meteoric costs associated with chronic illness by allowing for earlier intervention.
Next Generation Sequencing Market Segmentation:
The next generation sequencing market is divided into types of sequencing, product type, technology, application, end user and region & country level. Based on types of sequencing, the global next generation sequencing market is segmented into whole genome sequencing, targeted resequencing and whole exome sequencing. Based on product type, the market is divided into consumables, platforms and services. And based on technology, the market is segmented into sequencing by synthesis, ION semiconductor sequencing, nanopore sequencing, single molecule real time sequencing and other technologies. On the basis of application, the market is divided into diagnostics, drug discovery, agricultural and animal research and others. Based on end-user, the market is segmented into academic institutes, research centers, pharmaceuticals and biotechnology industries, hospitals and clinics and other.
By Type of Sequencing:
Whole Genome Sequencing
Targeted Resequencing
Whole Exome Sequencing
By Product Type:
Consumables
Platforms
Services
By Technology:
Sequencing by Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single Molecule Real Time Sequencing
Other Technologies
By Application:
Diagnostics
Drug Discovery
Agricultural and Animal research
Others
By End-User:
Academic Institutes
Research Centers
Pharmaceuticals and Biotechnology Industries
Hospitals and Clinics
Other
There are 15 Chapters to display the Global Next Generation Sequencing market.
Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Global Next Generation Sequencing market, Applications, Market Segment by Types
Chapter 2, objective of the study.
Chapter 3, to display Research methodology and techniques.
Chapter 4 and 5, to show the Next Generation Sequencing Market Analysis, segmentation analysis, characteristics;
Chapter 6 and 7, to show Five forces (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;
Chapter 8 and 9, to show analysis by regional segmentation[North America (Covered in Chapter 6 and 13), United States, Canada, Mexico, Europe (Covered in Chapter 7 and 13), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 8 and 13), China, Japan, South Korea, Australia, India, Southeast Asia, Others, Middle East and Africa (Covered in Chapter 9 and 13), Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others, South America (Covered in Chapter 10 and 13), Brazil, Argentina, Columbia, Chile & Others ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis
Chapter 10, to identify major decision framework accumulated through Industry experts and strategic decision makers;
Chapter 11 and 12, Global Next Generation Sequencing Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels
Chapter 13 and 14, about vendor landscape (classification and Market Ranking)
Chapter 15, deals with Global Next Generation Sequencing Market sales channel, distributors, Research Findings and Conclusion, appendix and data source.
Get Methodology: https://brandessenceresearch.com/requestMethodology/PostId/1600
About US:
Brandessence Market Research and Consulting Pvt Ltd
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London
Contact Us:
Alan Ruffalo,
Corporate Sales: +44-2038074155
Email: [email protected]
Related Report:
Drone Market in terms of revenue was worth of USD 18.28 Billion in 2020 and is projected to reach USD 40.90 Billion in 2027, growing at a CAGR of 12.27% from 2021 to 2027.
Personalized Medicine Market is valued at USD 489.1 Billion in 2020 and Growing with a CAGR of 6.32% over the forecast period.
Self-Storage Market size is estimated at USD 78.21 Billion in 2019 and expected to reach USD 123.14 Billion by 2026 with the CAGR of 7.2% over the forecast period.
-
Interviews4 days ago
Empowering Innovation in Insurance: A Conversation with Bhargav Kumar Konidena
-
Top Stories4 days ago
LME monitors tightness in aluminium market after spike in spread
-
Top Stories4 days ago
ECB’s top conservative shifts tone with sanguine inflation message
-
Interviews4 days ago
Debasish Paul on Driving Cloud Innovation at JPMorgan Chase: Balancing High-Tech Solutions with Business Impact